1. Treloar AE, Boynton BE, Behn BG, et al. Variations of the human menstrual cycle through reproductive life. Int J Fertil 1967; 12:77-126.

2. Vollman RF. The Menstrual Cycle. Philadelphia: WB Saunders, 1977.

3. Presser HB. Temporal data relating to the human menstrual cycle. In: Ferin M, Halber F, Richart RM, et al, eds. Biorhythms and Human Reproduction. New York: John Wiley & Sons, 1974:145-60.

4. Apter D, Raisanen I, Ylostalo P, et al. Follicular growth in relation to serum hormonal patterns in adolescence compared with adult menstrual cycles. Fertil Steril 1987; 47:82-88.

5. Fraser IS, Michie EA, Wide L, et al. Pituitary gonadotropin and ovarian function in adolescent dysfunctional uterine bleeding. J Clin Endocrinol Metab 1973; 37:407-14.

6. Lenton EA, Landgren B, Sexton L, Harper R. Normal variation in the length of the follicular phase of the menstrual cycle: effect of chronological age. Br J Obstet Gynaecol 1984; 91:681.

7. Groom MP, Illengworth PJ, O'Brian M, et al. Measure of dimeric inhibin throughout the human menstrual cycle. J Clin Endocrinol Metab 1996; 1:1401-1405.

8. Tsafriri A. Loal nonsteroidal regulators of ovarian function. In: Knobil E, Neill, JD, eds. The Physiology of Reproduction. 2nd ed, vol 1. New York: Raven, 1994: 817-860.

9. Sawetawan C, Carr BR, McGee E, et al. Inhibin and activin differentially regulate androgen production and 17-a-hydroxylase expression in human ovarian thecal-like tumor cells. J Endocrin 1996; 148:213-221.

10. Amsterdam A, Rotmensch S. Structure-function relationships during granulosa cell differentiation. Endocrin Rev 1987; 8:309-337.

11. Nimrod A, Erickson GF, Ryan KJ. A specific FSH receptor in rat granulosa cells: properties of binding in vitro. Endocrinology 1976; 98:56-64.

12. Fink G. Gonadotropin secretion and its control. In: Knobil E, Neill, JD, eds. The Physiology of Reproduction. 1st e, vol 1. New York: Raven, 1988: 1349-1377.

13. Zeleznik AJ, Midgley AR Jr, Reichert LE Jr. Granulosa cell maturation in the rat: increased binding of human chorionic gonadotropin following treatment with follicle stimulating hormone in vivo. Endocrinology 1974; 95: 818-825.

14. Erickson GF, Wang C, Hsueh AJW. FSH induction of functional LH receptors in granulosa cells cultured in a chemically defined medium. Nature 1979; 279: 336-338.

15. McNatty KP, Markis A, Reinhold VN, et al. Metabolism of androstenedione by human ovarian tissue in vitro with particular reference to reductase and aromatase activity. Steroids 1979; 34: 439-443.

16. Young JR, Jaffe RB. Strength-duration characteristics of estrogen effects on gonadatropin response to gonadotropin releasing hormone in women. II. Effects of various concentrations of estradiol. J Clin Endocrin Metab 1976, 42: 432.

17. Ream N, Saunder SE, Kelch Rp, et al. Pulsatile gonadotropin secretion during the menstrual cycle: evidence for altered frequency of gonadotropin releasing hormone secretion. J Clin Endocrin Metab 1984; 59:328.
18.
18. Zhou J, Bondy C. Anatomy of the human ovarian insulin-like growth factor system. Biol Reprod 1993; 48:467.

19. Maruo T, Ladines-Llave CA, Samoto T, et al. Expression of epidermal growth factor and its receptor in the human ovary during follicular growth and regression. Endocrinology 1993; 132:924.

20. Hillier SG, Van den Boogard AMJ, Reichert LE, et al. Intraovarian sex steroid hormone interactions and the regulation of follicular maturation: aromatization of androgens by human granulosa cells in vitro. J Clin Endocrinol Metab 1980; 50:640.

21. Paurstein CJ, Eddy CA, Croxatto HD, et al. Temporal relationships of estrogen, progesterone and luteinizing hormone levels to ovulation in women and infrahuman primates. Am J Obstet Gynecol 1978; 130:876.

22. Cahill DJ, Wardle PG, Harlow CR, Hull MGR. Onset of the preovulatory luteinizing hormone surge: diurnal timing and critical follicular prerequisites. Fertil Steril 1998; 70:56.

23. Channing CP, Schaerf FW, Anderson LD, et al. Ovarian follicular and luteal physiology. In: Greep RO, ed. International Review of Physiology. Vol 22. Baltimore: University Park Press, 1980; 22:117.

24. Espey LL, Lipner H. Ovulation. In Knobil E, Neill JD, eds. The Physiology of Reproduction. 2nd edition, Vol 1. New York: Raven, 1994: 725.

25. Espey LL. Ovarian proteolytic enzymes and ovulation. Biol Reprod 1974; 10:216.

26. Hodgen GD. The dominant ovarian follicle. Fertil Steril 198; 38:281.

27. Baird DT. A model for follicular selection and ovulation: lessons from superovulation. J Steroid Biochem 1987; 27:15.

28. Lumsden MA, Kelly RW, Templeton AA, et al. Changes in the concentrations of prostaglandins in preovulatory human follicles after administration of hCG. J Reprod Fertil 1986; 77:119.

29. Espey LL, Tanaka N, Adams RF, et al. Ovarian hydroxyeicodatetraenoic acids compared with prostanoids and asteroids during ovulation in rats. Am J Physiol 1991; 260:E163.

30. Sherman BM, West JH, Korenman SG. The menopausal tradition: Analysis of LH, FSH, estradiol, and progesterone concentrations during menstrual cycles of older women. J Clin Endocrin Metabol 1976; 42:629.

31. Doody KJ, Carr BR. Diagnosis and treatment of luteal dysfunction. In Hillier SG, ed. Ovarian Endocrinology. London: Blackwell Scientific, 1991: 260.

32 Pall M, Friden BE, Brannstrom M. Induction of delayed follicular rupture in the human by the selective COX-2 inhibitor rofecoxib: a randomized double-blind study. Hum Repod 2001; 16(7):1323.

33. Katt JA, Duncan JA, Herbon L, et al. The frequency of gonadotropin releasing hormone stimulation determines the number of pituitary gonadotropin releasing hormone receptors. Endocrinology 1985; 116:2113.

34. Koos RD. Potential relevance of angiogenic factors to ovarian physiology. Semin Reprod Endocrinol 1989; 7:29.

35. Niswender GD, Nett TM. The corpus luteum and its control in infraprimate species. In: Knobil E, Neill, JD, eds. The Physiology of Reproduction. 2nd ed, vol 1. New York: Raven, 1994: 781.

36. Retamales I, Carrasco I, Tronocoso JL, et al. Morpho-functional study of human luteal cell sub-populations. Human Reprod 1994; 9: 591.

37. Khan-Dawood FS, Goldsmith LT, Weiss G, et al. Human corpus luteum secretion of relaxin, oxytocin and progesterone. J Clin Endocrin Metab 1989; 68:627.

38. Carr BR, McGee EA, Sawetawan C, et al. The effect of transforming growth factor beta on steroidogenesis and expression of key steroidogenic enzymes using a human ovarian theca-like tumor cell model. Am J Obstet Gynecol 1996; 174(4):1109-1116.

39. Vande Wiele RL, Bogumil J, Dyrenfurth I, et al. Mechanisms regulating the menstrual cycle in women. Recent Prog Horm Res 1970; 26:63.

40. Segaloff A, Sternberg WH, Gaskill CJ. Effects of luteotropic doses of chorionic gonadotropin in women. J Clin Endocrin Metab 1951; 11:936.

41. Filicori M, Butler JP, Crowley WF. Neuroendocrine regulation of the corpus luteum in the human. J Clin Invest 1984; 73:1638.

42. McNeely MJ, Soules MR. The diagnosis of luteal phase deficiency. Fertil Steril 1988; 50:1.

43. Stouffer RL, Hodgen GD. Induction of luteal phase defects in rhesus monkeys by follicular fluid administration at the onset of the menstrual cycle. J Clin Endocrin Metab 1980; 51:669.

44. Sheehan KL, Casper RF, Yen SSC. Luteal phase defects induced by an agonist of luteinizing homone releasing factor: A model for fertility control. Science 1982; 215:170.

45. Keyes PL, Wiltbank MC. Endocrine regulation of the corpus luteum. Annu Rev Physiol 1988; 50:465.

46. Cooke ID. The corpus luteum. Human Reprod 1988; 3:153.

47. Auletta FJ, Flint APF. Mecahnisms controlling corpus luteum function in sheep, cows, non-human primates and women especially in relation to the time of luteolysis. Endocr Rev 1988; 9:88.

48. Hodgen GD. Surrogate embryo transfer combined with estrogen-progesterone therapy in monkeys. Implantation, gestation and delivery without ovaries. JAMA 1983; 250:2167.

49. Gore BZ, Caldwell B, Speroff L. Estrogen-induced human luteolysis. J Clin Endocrinol Metab 1973; 36:615.

50. Iiwai T, Nanbu Y, Iwai M, et al. Immunohistochemical localization of oestrogen receptors and progesterone receptors in the human ovary throughout the menstrual cycle. Virchows Arch A 1990; 417:319.

51 Auletta FJ. The role of prostaglandin F2-a in human luteolysis. Contemp Obstet Gynecol 1987; 30:119.

52. Wentz AC, Jones GS. Transient luteolytic effect of prostaglandin F2-a in the human. Obstet Gynecol 1973; 42:172.

53. Schoonmaker JN, Bergman KS, Steiner RA, et al. Estradiol-induced luteal regression in the rhesus monkey: evidence of an extra-ovarian site of action. Endocrinology 1984; 110:1708.

54. Shikone T, Yamoto M, Kokawa K, et al. Apoptosis of human corpora lutea during cyclic luteal regression and early pregnancy. J Clin Endocrinol Metab 1996; 81:2376.

55. Khan-Dawood FS, Huang JC, Dawood MY. Baboon corpus luteum oxytocin: an intragonadal peptide modulator on luteal function. Am J Obstet Gynecol 1988; 158:882.

56. Judd HL, Yen SSC. Serum androstenedione and testosterone levels during the menstrual cycle. J Clin Endocrinol Metab 1973; 36:475.

57. Genazzani AR, Lemarchand-Beraud TH, Aubert ML, et al. Pattern of plasma ACTH, hGH and cortisol during the menstrual cycle. J Clin Endocrinol Metab 1975; 41:431.

58. Carr BR, Parker Jr CR, Madden JD, et al. Plasma levels of adrenocorticotropin (ACTH) and cortisol in women receiving oral contraceptive treatment. J Clin Endocrinol Metab 1979; 49:346.

59. Carr BR, Wilson JD. Disorders of the ovary and female reproductive tract. In: Braunwald E, Isselbacher KJ, Petersdorf RG, et al, eds. Harrison's Principles of Internal Medicine. 11th ed. New York: McGraw-Hill, 1987: 1818.

60. Casey ML, MacDonald PC. Extraadrenal formation of a mineralocorticosteroid: deoxycorticosterone and deocycorticosterone sulfate biosynthesis and metabolism. Endocr Rev 1982; 3:396.

61. Parker Jr CR, Winkel CA, Rush AJ, et al. Plasma concentrations of 11-deocycorticosterone in women during the menstrual cycle. Obstet Gynecol 1981; 58:26.

62. Noyes RW, Hertig AW, Rock J. Dating the endometrial biopsy. Fertil Steril 1950; 1:3.

63. Lessy BA, Killman AP, Metzger DA, et al. Immunohistochemical analyses of human uterine estrogen and progesterone receptors throughout the menstrual cycle. J Clin Endocrinol Metab 1988; 69:334.

64. Tseng L, Liu HC. Stimulation of arylsulfotransferase activity by progestins in human endometrium in vitro. J Clin Endocrinol Metab 1981; 53:418.

65. Rebar RE. Practical evaluation of hormonal status. In: yen SSC, Jaffe RB, eds. Reproductive Endocrinology: Physiology, Pathophysiology and Clinical Management. 3rd Ed. Philadelphia: WB Saunders 1991: 830.

66. Gaudefoy M. Cytologic criteria of estrogen effect. Acta Cytol 1958; 2:347.

67. Henzl MR, Smith RE, Boost G, et al. Lysosomal concept of menstrual bleeding in humans J Clin Endocrinol Metab 1972; 34:860.

68. Turksoy RN, Safaii HS. Immediate effect of prostaglandin F2a during the luteal phase of the menstrual cycle. Fertil Steril 1975; 26:634.

69. Edman CD. The effects of steroids on the endometrium. Semin Reprod Endocrinol 1983; 1:79.

70. Curry TE Jr, Osteen KG. Cyclic changes in the matrix metalloproteinase system in the ovary and uterus. Biol Reprod 2001; 64(5):1285.

71. Hallberg L, Hogdahl A, Nilsson L, et al. Menstrual blood loss: a population study. Acta Obstet Gynecol Scand 1966; 45:320.